Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

OPTIMIZING ANIMAL MODELS AND EXPERIMENTAL DESIGNS FOR ENDOCRINE DISRUPTOR RESEARCH AND TESTING

View through CrossRef
Growing evidence suggests that environmental chemicals can disrupt normal endocrine functions, causing developmental and reproductive abnormalities in fish and wildlife. This has raised concerns about potential human health risks. Consequently, US legislation now mandates the Environmental Protection Agency (EPA) to create and validate a screening program to identify chemicals in food and water that may act as endocrine disruptors. In response, the EPA proposed the Endocrine Disruptor Screening Program, which employs both in vitro and in vivo test systems to identify harmful chemicals for humans and ecologically significant species. However, the endocrine system is highly sensitive to various experimental factors, such as diet and the genetic background of the test animals. To ensure accurate results in endocrine disruptor research, it is crucial to minimize or eliminate factors that contribute to experimental variation. Standard laboratory animal diets, for instance, contain varying levels of phytoestrogens that can mimic the effects of both endogenous and exogenous estrogens. Additionally, studies have shown that some commonly used outbred mice and rats exhibit lower sensitivity to estrogenic substances compared to certain inbred strains. Thus, selecting appropriate biological models and diets that offer optimal sensitivity and specificity is essential for endocrine disruptor studies. This issue introduces 11 papers that delve into critical experimental design considerations and review current laboratory animal and in vitro models used in endocrine disruptor research. Careful selection of animal models and experimental design parameters will minimize confounding variables, enhance the reproducibility of results, and lead to more reliable and relevant test systems.
Title: OPTIMIZING ANIMAL MODELS AND EXPERIMENTAL DESIGNS FOR ENDOCRINE DISRUPTOR RESEARCH AND TESTING
Description:
Growing evidence suggests that environmental chemicals can disrupt normal endocrine functions, causing developmental and reproductive abnormalities in fish and wildlife.
This has raised concerns about potential human health risks.
Consequently, US legislation now mandates the Environmental Protection Agency (EPA) to create and validate a screening program to identify chemicals in food and water that may act as endocrine disruptors.
In response, the EPA proposed the Endocrine Disruptor Screening Program, which employs both in vitro and in vivo test systems to identify harmful chemicals for humans and ecologically significant species.
However, the endocrine system is highly sensitive to various experimental factors, such as diet and the genetic background of the test animals.
To ensure accurate results in endocrine disruptor research, it is crucial to minimize or eliminate factors that contribute to experimental variation.
Standard laboratory animal diets, for instance, contain varying levels of phytoestrogens that can mimic the effects of both endogenous and exogenous estrogens.
Additionally, studies have shown that some commonly used outbred mice and rats exhibit lower sensitivity to estrogenic substances compared to certain inbred strains.
Thus, selecting appropriate biological models and diets that offer optimal sensitivity and specificity is essential for endocrine disruptor studies.
This issue introduces 11 papers that delve into critical experimental design considerations and review current laboratory animal and in vitro models used in endocrine disruptor research.
Careful selection of animal models and experimental design parameters will minimize confounding variables, enhance the reproducibility of results, and lead to more reliable and relevant test systems.

Related Results

High tumor copy number variations burden was associated with poor prognosis in patients with endocrine-resistant breast cancer
High tumor copy number variations burden was associated with poor prognosis in patients with endocrine-resistant breast cancer
Abstract Background Several studies have showed alterations in genes were associated with endocrine resistance in breast cancer. Nevertheless, genomic characteristics in p...
Endocrine treatment of breast cancer
Endocrine treatment of breast cancer
Abstract Endocrine manipulation has been recognized as a treatment modality for breast cancer for over 100 years. Oestrogen is an important promoter in the pathogene...
Animal welfare in Europe and Iran: policy perspective and society
Animal welfare in Europe and Iran: policy perspective and society
Intensive animal production systems are compromising current animal welfare standards. Societies' growing concerns regarding how animals are raised have resulted in continuous poli...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash INTRODUCTION The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
Endocrine Treatment of Breast Cancer: Current Perspectives, Future Directions
Endocrine Treatment of Breast Cancer: Current Perspectives, Future Directions
Breast cancer remains one of the major causes of death in women, and endocrine treatment is currently one of the mainstay of treatment in patients with estrogen receptor positive b...
Lapatinib Restores Endocrine Sensitivity in Selected Patients with Estrogen Receptor (ER) Positive Metastatic Breast Cancer.
Lapatinib Restores Endocrine Sensitivity in Selected Patients with Estrogen Receptor (ER) Positive Metastatic Breast Cancer.
Abstract Background:Breast cancer cell lines achieve a state of resistance to antiestrogens and to estrogen withdrawal or aromatase inhibitors by utilizing other gro...
An endocrine role for brown adipose tissue?
An endocrine role for brown adipose tissue?
White adipose tissue is recognized as both a site of energy storage and an endocrine organ that produces a myriad of endocrine factors called adipokines. Brown adipose tissue (BAT)...

Back to Top